Malli, I.; Kumari, N.; Dubrovsky, L.; Ivanov, A.; Bukrinsky, M.; Nekhai, S.; Dakshanamurthy, S.; Ullah, H. Host-Targeted Antivirals Inhibit RACK1-mediated IRES Activities in HIV-1 Infection. Preprints2021, 2021040692. https://doi.org/10.20944/preprints202104.0692.v1
Malli, I., Kumari, N., Dubrovsky, L., Ivanov, A., Bukrinsky, M., Nekhai, S., Dakshanamurthy, S., & Ullah, H. (2021). Host-Targeted Antivirals Inhibit RACK1-mediated IRES Activities in HIV-1 Infection. Preprints. https://doi.org/10.20944/preprints202104.0692.v1
Malli, I., Sivanesan Dakshanamurthy and Hemayet Ullah. 2021 "Host-Targeted Antivirals Inhibit RACK1-mediated IRES Activities in HIV-1 Infection" Preprints. https://doi.org/10.20944/preprints202104.0692.v1
Host ribosome-associated scaffold protein Receptor for Activated C Kinase 1 (RACK1) is utilized by a diverse group of human viruses for Internal Ribosomal Entry Sites (IRES) – mediated translation of viral mRNAs. We recently reported inhibition of herpes virus by small molecules targeting the RACK1 functional site. Here, we tested these molecules against HIV-1 and HCV, as HIV-1 contains two potential IRES sites and HCV translation occurs exclusively through IRES. Compounds significantly downregulated activities of HIV-1- and HCV-related dicistronic reporter constructs in transfected HEK293T cells. The compounds also strongly downregulated production of the HIV-1 capsid protein p24 in HIV-infected cells, as well as production of HIV-1 Gag precursor p55 and p55-derived proteins p24 and p17 in cells infected with the HIV-1 virus. Hepatitis C virus (HCV) IRES activities were also significantly inhibited by RACK1 inhibitor compounds. Since a number of human and plant pathogenic viruses are reported to use IRES, the RACK1 compounds can be established as broad host-targeted antivirals.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.